ORGN · As filed with the SEC
Origin Materials balance sheet, by fiscal year
The statement as Origin Materials presents it in its 10-Q and 10-K: its own lines, labels and order. Tables over time lines up standardized figures across every filing.
CONSOLIDATED BALANCE SHEETS · USD thousands
| USD thousands | FY2025 Dec 31, 2025 | FY2024 Dec 31, 2024 | FY2023 Dec 31, 2023 | FY2022 Dec 31, 2022 |
|---|---|---|---|---|
| ASSETS | ||||
| Current assets | ||||
| Cash and cash equivalents | 32,923 | 56,307 | 75,502 | 107,858 |
| Restricted cash | — | — | 0 | 490 |
| Marketable securities | 20,545 | 46,613 | 82,761 | 215,464 |
| Accounts receivable net of allowance for credit losses of $828 and $1,230, respectively | 13,049 | 19,179 | 16,128 | — |
| Other receivables | 2,101 | 2,526 | 3,449 | 4,346 |
| Derivative asset | — | — | — | 0 |
| Inventory | 684 | 866 | 912 | — |
| Prepaid expenses and other current assets | 2,448 | 2,401 | 8,360 | 3,341 |
| Land held for sale | 9,126 | 11,282 | — | — |
| Total current assets | 80,876 | 139,174 | 187,112 | 331,499 |
| Property, plant, and equipment, net | 72,852 | 203,919 | 243,118 | 154,183 |
| Operating lease right-of-use asset | 3,149 | 3,735 | 4,468 | 2,779 |
| Intangible assets, net | 32 | 73 | 121 | 160 |
| Deferred tax assets | 0 | 621 | 1,261 | — |
| Other long-term assets | 751 | 30,505 | 25,754 | 5,079 |
| Total assets | 157,660 | 378,027 | 461,834 | 493,700 |
| LIABILITIES AND STOCKHOLDERS’ EQUITY | ||||
| Current liabilities | ||||
| Accounts payable | 3,568 | 2,921 | 1,858 | 10,384 |
| Accrued expenses | 4,947 | 2,779 | 7,689 | 8,414 |
| Operating lease liabilities, current | 306 | 323 | 367 | 619 |
| Notes payable, short-term | 4,511 | 3,772 | 1,730 | — |
| Convertible notes, net of issuance costs | 14,970 | — | — | — |
| Other liabilities, current | 231 | 2,754 | 918 | 51 |
| Derivative liability | — | 0 | 300 | 344 |
| Total current liabilities | 28,533 | 12,549 | 12,862 | 19,812 |
| Earnout liability | 24 | 2,486 | 1,783 | 42,533 |
| Canadian Government Research and Development Program liability | 16,776 | 14,399 | 7,348 | 7,185 |
| Assumed common stock warrants liability | — | — | — | 30,872 |
| Stockholder note | — | — | — | 5,847 |
| Related party other liabilities, long-term | — | — | — | 5,395 |
| Common stock warrants liability | 167 | 4,566 | 1,341 | — |
| Notes payable, long-term | 4,386 | 1,730 | 3,459 | — |
| Operating lease liabilities | 3,533 | 3,858 | 4,207 | 2,249 |
| Other liabilities, long-term | 30 | 74 | 8,327 | 2,902 |
| Total liabilities | 53,449 | 39,662 | 39,327 | 116,795 |
| STOCKHOLDERS’ EQUITY | ||||
| Preferred stock, $0.0001 par value, 10,000,000 shares authorized; no shares issued and outstanding as of December 31, 2025 and 2024 | 0 | 0 | 0 | 0 |
| Common stock, $0.0001 par value, 1,000,000,000 shares authorized; 5,173,884 and 4,952,476, issued and outstanding as of December 31, 2025 and 2024, respectively (including 50,000 and 100,000, respectively, of Sponsor Vesting Shares) | 15 | 15 | 15 | 14 |
| Additional paid-in capital | 402,378 | 393,186 | 382,854 | 371,072 |
| Accumulated deficit | (287,825) | (38,127) | 45,570 | 21,772 |
| Accumulated other comprehensive loss | (10,357) | (16,709) | (5,932) | (15,953) |
| Total stockholders’ equity | 104,211 | 338,365 | 422,507 | 376,905 |
| Total liabilities and stockholders’ equity | 157,660 | 378,027 | 461,834 | 493,700 |
As filed on EDGAR · Not affiliated with the U.S. SEC · Not investment advice. Each column links to its filing.